Relation between the Level of Soluble Endothelial Protein C Receptor and the Risk of Deep Venous Thrombosis in Sudanese

Hytham Ahmed Abuagla¹, Awad Omer Ahmed², Ahmed Kamal Bolad³, Khalid Mohamed Adam¹

¹Faculty of Applied Medical Science, Department of Medical Lab Science, Bisha University, Bisha, Saudi Arabia.
²Department of Hematology, Royal Care International Hospital, Khartoum, Sudan.
³Graduate College, Alneelain University, Khartoum, Sudan.

DOI: 10.4236/oalib.1102241                

Abstract

Background: Deep vein thrombosis (DVT) may lead to serious complication; the pulmonary embolism; one of the most serious conditions that cause morbidity and mortality worldwide. sEPCR circulates in the plasma and has high affinity to bind protein C and activated protein C (APC). This binding interferes with the anticoagulant function of APC and results in increased risk for DVT. The aim of this study is to explore the role of sEPCR as a risk factor for DVT in Sudanese individuals. Methods: A total of 100 Sudanese DVT patients and 100 apparently healthy individuals were recruited for this study. EDTA-anticoagulated venous blood samples were collected from all participants. Plasma sEPCR levels were measured by enzyme linked immunosorbent Assay (ELISA). All results were analyzed using SPSS. Results: The plasma level of sEPCR was higher in DVT group than in healthy individuals, while male patients showed higher level when compared to females. Age correlates positively with sEPCR, whilst BMI and ethnicity showed no effect on the level of sEPCR. Individuals in the top quartiles of showed to increased risk of DVT when compared to those in the lower quartile. Conclusion: It can be concluded that elevated sEPCR level increases the risk to develop DVT in Sudanese. The level of the soluble receptor is influenced by the gender of individual more than by his/her ethnicity or body mass index. Results are also indicative of a much higher risk in those with sEPCR level more than 120 ng/ml when compared to those with lower levels.

Keywords

Deep Vein Thrombosis, sEPCR, Pulmonary Embolism, EPCR, Sudanese

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Douketis, J.D. (n.d.) Deep Vein Thrombosis (DVT). http://www.merckmanuals.com/home/heart-and-blood-vessel-disorders/venous-disorders/deep-vein-thrombosis-dvt
[2]	Kesieme, E., Kesieme, C., Jebbin, N., Irekpita, E. and Dongo, A. (2011) Deep Vein Thrombosis: A Clinical Review. Journal of Blood Medicine, 2, 59-69. http://dx.doi.org/10.2147/JBM.S19009
[3]	Sirlak, M., Inan, M.B., Cetintas, D. and Ozcinar, E. (2012) Risk Factors of Deep Vein Thrombosis. In: Cheng, G., Ed., Deep Vein Thrombosis, InTech, p. 1. http://www.intechopen.com/books/deep-vein-thrombosis/risk-factors-of-deep-vein-thrombosis"title="RiskFactorsofDeepVeinThrombosis">RiskFactorsofDeepVeinThrombosis30
[4]	Rosendaal, F.R. and Reitsma, P.H. (2009) Genetics of Venous Thrombosis. Journal of Thrombosis and Haemostasis, 7, 301-304. http://dx.doi.org/10.1111/j.1538-7836.2009.03394.x
[5]	Wong, P. and Baglin, T. (2012) Epidemiology, Risk Factors and Sequelae of Venous Thromboembolism. Phlebology, 27, 2-11. http://dx.doi.org/10.1258/phleb.2012.012S31
[6]	Fukudome, K. and Esmon, C.T. (1994) Identification, Cloning, and Regulation of a Novel Endothelial Cell Protein C/Activated Protein C Receptor. The Journal of Biological Chemistry, 269, 26486-26491.
[7]	Kurosawa, S., Stearns-Kurosawa, D.J., Hidari, N. and Esmon, C.T. (1997) Identification of Functional Endothelial Protein C Receptor in Human Plasma. Journal of Clinical Investigation, 100, 411-418. http://dx.doi.org/10.1172/JCI119548
[8]	Raife, T.J. and Lentz, S.R. (2005) The Benefits of Excess EPCR. Journal of Thrombosis and Haemostasis, 3, 1349-1350. http://dx.doi.org/10.1111/j.1538-7836.2005.01462.x
[9]	Saposnik, B., Reny, J.L., Gaussem, P., Emmerich, J., Aiach, M. and Gandrille, S. (2004) A Haplotype of the EPCR Gene Is Associated with Increased Plasma Levels of sEPCR and Is a Candidate Risk Factor for Thrombosis. Blood, 103, 1311-1318. http://dx.doi.org/10.1182/blood-2003-07-2520
[10]	de Willige, U.S., Marion, V., Rosendaal, F.R., Vos, H.L., De Visser, M.C. and Bertina, R.M. (2004) Haplotypes of the EPCR Gene, Plasma sEPCR Levels and the Risk of Deep Venous Thrombosis. Journal of Thrombosis and Haemostasis, 2, 1305-1310. http://dx.doi.org/10.1046/j.1538-7836.2004.00855.x
[11]	Karabiyik, A., Yilmaz, E., Egin, Y. and Akar, N. (2012) The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients. Turkish Journal of Haematology, 29, 55-62.
[12]	Ducros, E., Mirshahi, S.S., Faussat, A.M., Mirshahi, P., Dimicoli, S., Tang, R., et al. (2012) Soluble Endothelial Protein C Receptor (sEPCR) Is Likely a Biomarker of Cancer-Associated Hypercoagulability in Human Hematologic Malignancies. Cancer Medicine, 1, 261-267. http://dx.doi.org/10.1002/cam4.11
[13]	Abd-Elghfaar, A.A., Ismail, M.M., Farweez, B.A. and Elmasry, R.F. (2013) Influence of Soluble Endothelial Protein C Receptor (sEPCR) on Hypercoagulable State of Haemodialysis Patients. International Journal of Science and Research, 4, 1123-1128.
[14]	Stearns-Kurosawa, D.J., Swindle, K., D’Angelo, A., Della, V.P., Fattorini, A., Caron, N., et al. (2002) Plasma Levels of Endothelial Protein C Receptor Respond to Anticoagulant Treatment. Blood, 99, 526-530. http://dx.doi.org/10.1182/blood.V99.2.526
[15]	Yin, G., Jin, X., Ming, H., Zheng, X. and Zhang, D. (2012) Endothelial Cell Protein C Receptor Gene 6936A/G Polymorphism Is Associated with Venous Thromboembolism. Experimental and Therapeutic Medicine, 3, 989-992.
[16]	Chen, X.D., Tian, L., Zheng, C.F., Li, M., Jin, W., Wang, X.H., et al. (2010) Relationship between Endothelial Protein C Receptor Gene 6936A/G Polymorphisms and Deep Venous Thrombosis. Chinese Journal of Hematology, 31, 607-609.
[17]	Wang, X.Z. (2008) Association between Gene Polymorphism of Endothelial Cell Protein C Receptor and Thrombotic Disease in Chinese Han Population of Hubei District. Huazhong University of Science and Technology, Wuhan.
[18]	Navarro, S., Medina, P., Mira, Y., Estelles, A., Villa, P., Ferrando, F., et al. (2008) Haplotypes of the EPCR Gene, Prothrombin Levels, and the Risk of Venous Thrombosis in Carriers of the Prothrombin G20210A Mutation. Haematologica, 93, 885-891. http://dx.doi.org/10.3324/haematol.12448
[19]	Xu, J., Qu, D., Esmon, N.L. and Esmon, C.T. (2000) Metalloproteolytic Release of Endothelial Cell Protein C Receptor. Journal of Biological Chemistry, 275, 6038-6044. http://dx.doi.org/10.1074/jbc.275.8.6038
[20]	Gu, J.M., Katsuura, Y., Ferrell, G.L., Grammas, P. and Esmon, C.T. (2000) Endotoxin and Thrombin Elevate Rodent Endothelial Cell Protein C Receptor mRNA Levels and Increase Receptor Shedding in Vivo. Blood, 95, 1687-1693.
[21]	Pintao, M.C., Roshani, S., De Visser, M.C., Tieken, C., Tanck, M.W., Wichers, I.M., et al. (2011) High Levels of Protein C Are Determined by PROCR Haplotype 3. Journal of Thrombosis and Haemostasis, 9, 969-976. http://dx.doi.org/10.1111/j.1538-7836.2011.04256.x
[22]	Qu, D., Wang, Y., Esmon, N.L. and Esmon, C.T. (2007) Regulated Endothelial Protein C Receptor Shedding Is Mediated by Tumor Necrosis Factor-Alpha Converting Enzyme/ADAM17. Journal of Thrombosis and Haemostasis, 5, 395-402. http://dx.doi.org/10.1111/j.1538-7836.2007.02347.x
[23]	Guitton, C., Gerard, N., Quillard, T. and Charreau, B. (2011) Circulating Endothelial Cell Protein C Receptor: Endothelial Regulation and Cumulative Impact of Gender and A3 Haplotype. Journal of Vascular Research, 48, 336-346. http://dx.doi.org/10.1159/000322582
[24]	Stearns-Kurosawa, D.J., Burgin, C., Parker, D., Comp, P. and Kurosawa, S. (2003) Bimodal Distribution of Soluble Endothelial Protein C Receptor Levels in Healthy Populations. Journal of Thrombosis and Haemostasis, 1, 855-856. http://dx.doi.org/10.1046/j.1538-7836.2003.t01-4-00115.x
[25]	Orhon, F.S., Ergun, H., Egin, Y., Ulukol, B., Baskan, S. and Akar, N. (2010) Soluble Endothelial Protein C Receptor Levels in Healthy Population. Journal of Thrombosis and Haemostasis, 29, 46-51. http://dx.doi.org/10.1007/s11239-009-0329-z
[26]	Auerswald, G., Scharrer, I., Kurth, A., Schramm, W., Oldenburg, J., Schramm, W., et al. (2007) 36th Hemophilia Symposium Hamburg 2005: Epidemiology; Hemophilia Therapy—Management of Bleedings and Inhibitors; Orthopedic Treatment in Hemophiliacs; Hemostaseologic Diagnosis; Pediatric Hemostaseology; Free Lectures. Springer, Berlin Heidelberg.
[27]	Yamagishi, K., Cushman, M., Heckbert, S.R., Tsai, M.Y. and Folsom, A.R. (2009) Lack of Association of Soluble Endothelial Protein C Receptor and PROCR 6936A/G Polymorphism with the Risk of Venous Thromboembolism in a Prospective Study. British Journal of Haematology, 145, 221-226. http://dx.doi.org/10.1111/j.1365-2141.2009.07612.x